Cancer Drug Development Forum (CDDF)

The Cancer Drug Development Forum (CDDF) is a non-profit organisation registered in Belgium that provides a neutral platform to stimulate interaction between stakeholders involved in cancer drug development.

The CDDF’s mission is to facilitate collaboration between stakeholders, to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.

Its integrative approach brings together leading voices from academia, the pharmaceutical industry, regulatory authorities, policymakers and patient advocacy groups to improve cancer treatment.

Established in 2001 as the Biotherapy Development Association (BDA), the focus was initially around immunotherapy. Recognizing the importance of embracing all forms of oncology drug development, the name of the organization was changed in 2014 to the Cancer Drug Development Forum (CDDF).

The CDDF is organized around separate themes - a working group covering general issues in cancer drugs, a working group covering immunology and a working group covering paediatric oncology.

Mission:
CDDF’s mission is to facilitate collaboration between stakeholders to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.